Step-down therapy in asthma: A focus on treatment options for patients receiving inhaled corticosteroids and long-acting beta-agonist combination therapy

Allergy and Asthma Proceedings

Volumn 33, Issue 1, 2012, Pages 13-18

  Bacharier, Leonard B ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; LONG ACTING DRUG; MONTELUKAST; SALBUTAMOL; SALMETEROL;

ASTHMA; BONE DENSITY; CATARACT; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; FORCED EXPIRATORY VOLUME; GOLD STANDARD; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; LOW DRUG DOSE; MEDICAL DECISION MAKING; REVIEW; RISK REDUCTION; SIDE EFFECT; SKIN; TREATMENT DURATION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ASTHMA; CLINICAL PROTOCOLS; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HUMANS; INDIVIDUALIZED MEDICINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84857479192     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3493     Document Type: Review

References (16)

1. National Asthma Education and Prevention Program. Expert Panel Report III: Guidelines for the diagnosis and management of asthma. U.S. Department of Health and Human Services, Bethesda, MD, 2007.
2. Chowdhury BA, and Dal Pan G. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med 362:1169-1171, 2010.
3. Chowdhury BA, Seymour SM, and Levenson MS. Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma. N Engl J Med 364:2473-2475, 2011.
4. Lemanske RF Jr, and Busse WW. The US Food and Drug Administration and long-acting beta2-agonists: The importance of striking the right balance between risks and benefits of therapy? J Allergy Clin Immunol 126:449-452, 2010.
5. Lemanske RF Jr, Sorkness CA, Mauger EA, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: A randomized controlled trial. JAMA 285:2594-2603, 2001. (Pubitemid 32479899)
6. Martinez FD, Chinchilli VM, Morgan WJ, et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): A randomised, double-blind, placebo-controlled trial. Lancet 377:650-657, 2011.
7. Koenig SM, Ostrom N, Pearlman D, et al. Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down." J Asthma 45:681-687, 2008.
8. Berger WE, Bleecker ER, O'Dowd L, et al. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: Randomized controlled trial comparing once- and twice-daily dosing in patients with asthma. Allergy Asthma Proc 31:49-59, 2010.
9. Bateman ED, Jacques L, Goldfrad C, et al. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. J Allergy Clin Immunol 117: 563-570, 2006. (Pubitemid 43340219)
10. Godard P, Greillier P, Pigearias B, et al. Maintaining asthma control in persistent asthma: Comparison of three strategies in a 6-month double-blind randomised study. Respir Med 102: 1124-1131, 2008.
11. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 170:836-844, 2004. (Pubitemid 39346477)
12. Reddel HK, Gibson PG, Peters MJ, et al. Down-titration from high-dose combination therapy in asthma: Removal of longacting beta(2)-agonist. Respir Med 104:1110-1120, 2010.
13. Deykin A, Wechsler ME, Boushey HA, et al. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med 175:228-234, 2007. (Pubitemid 46203125)
14. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the diagnosis and management of asthma. U.S. Department of Health and Human Services, Bethesda, MD, 1997.
15. Friedman H, Wilcox T, Reardon G, et al. A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population. Clin Ther 30:1908-1917, 2008.
16. Colice GL, Yu AP, Ivanova JI, et al. Costs and resource use of mild persistent asthma patients initiated on controller therapy. J Asthma 45:293-299, 2008. (Pubitemid 351630916)